Lung Kee (HKG:0255) forecasts its loss will narrow up to HK$5 million in the first half from HK$24 million in the year-ago period, according to a Friday filing with the Hong Kong bourse.
The lower net loss is attributable to higher profit margins due to an increase in selling prices, more machining services and lower purchase prices of raw materials, the filing said.
The mold-based business plans to release H1 results before the end of August.
Shares closed 2% lower on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.